April 6, 2021
2,568
14
8
0.86%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:53Now PlayingAntibodies to the Covid-19 virus persist for at least six months after patients receive the second dose of Moderna Inc.’s vaccine, according to a new analysis of lab results from 33 healthy adults in the drugmaker’s phase one trial.
The finding, by researchers at the National Institute of Allergy and Infectious Diseases, Emory University, Moderna and elsewhere, was published as a brief correspondence in the New England Journal of Medicine. The researchers had previously published three-month followup results from the phase 1 study in the same journal.
“Our data show antibody persistence and thus support the use of this vaccine in addressing the Covid-19 pandemic,” the researchers wrote. Still, because it was focused on lab tests of blood samples from a small number of people in Moderna’s phase 1 trial, the study didn’t directly measure how durable the vaccine’s efficacy will be in actual practice.
Moderna shares rose as much as 6.4% in New York trading on Tuesday.
Subscribe to our YouTube channel
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.